longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Edesa Biotech(EDSA.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watch

rttnews·Yesterday at 17:04
US
ADIL
+14.08%
US
BDTX
+20.00%
US
EDSA
-8.54%
rttnews·Yesterday at 17:04
US
ADIL
+14.08%
US
BDTX
+20.00%
US
EDSA
-8.54%

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga_article·05/20/2026 01:06
US
AMIX
+18.65%
US
WOK
-19.57%
US
MTVA
+53.72%
benzinga_article·05/20/2026 01:06
US
AMIX
+18.65%
US
WOK
-19.57%
US
MTVA
+53.72%

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference | EDSA Stock News

StockTitan·05/19/2026 13:15
US
EDSA
-8.54%
US
BIB
+4.98%
US
LABU
+11.76%
StockTitan·05/19/2026 13:15
US
EDSA
-8.54%
US
BIB
+4.98%
US
LABU
+11.76%

Edesa Biotech | 8-K: FY2026 Q2 Revenue: USD 0

Earnings Watch·05/15/2026 04:53
US
EDSA
-8.54%
Earnings Watch·05/15/2026 04:53
US
EDSA
-8.54%

Pre-market hot trades in US stocks: Edesa Biotech up 9.27% in pre-market; Aehr Test up 7.20% in pre-market

Price Alert·05/13/2026 18:02
US
EDSA
-8.54%
US
AEHR
+1.49%
Price Alert·05/13/2026 18:02
US
EDSA
-8.54%
US
AEHR
+1.49%
© 2026 Longbridge|Disclaimer

Event Tracking

May15
Edesa Biotech released FY2026 Q2 earnings on May 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4938 (forecast USD -0.26)
03:00
Feb14
Edesa Biotech released FY2026 Q1 earnings on February 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2819 (forecast USD -0.45)
04:00
Dec13
Edesa Biotech released FY2025 Q4 earnings on December 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3158 (forecast USD -0.2666)
04:00
Edesa Biotech released FY2025 annual earnings on December 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.2657 (forecast USD -1.17)
04:00
Oct29
Edesa Biotech's EB05 Shows Positive Results in Phase 3 Clinical Trials for ARDS
10:21
Sep30
Edesa Biotech Inc. revises financing agreement with the Canadian government for ARDS drug development
20:15

Schedules & Filings

Schedules
Filings
May14
Earning Release(EST)

FY2026 Q2 Earning Release (USD) Net Income -4.218 M, EPS -0.4938

Feb13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -2.248 M, EPS -0.2819

Dec12
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -2.228 M, EPS -0.3158

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
6.080
+2,485.03%
+5.845
HCWB
2.430
+129.25%
+1.370
SLXN
0.5298
+96.95%
+0.261
VIDA
4.150
+81.22%
+1.860
GCL
0.7445
+72.46%
+0.313
PHGE
0.5969
+59.60%
+0.223
MTVA
2.890
+53.72%
+1.010
MWC
7.150
+51.48%
+2.430
PETZ
1.150
+41.98%
+0.340
MLGO
5.360
+39.95%
+1.530
View More